683 Capital Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History

683 Capital Management, LLC

$1.1 Billion
Q3 2024

A detailed history of 683 Capital Management, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, 683 Capital Management, LLC holds 123,300 shares of ALNY stock, worth $29 Million. This represents 3.08% of its overall portfolio holdings.

Number of Shares

123,300

Previous 122,900 0.33%

Holding current value

$29 Million

Previous $29.9 Million 13.57%

% of portfolio

3.08%

Previous 2.72%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $1.2 Million - $1.69 Million	-10,000 Reduced 20.41%	39,000 $5.69 Million
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $1.02 Million - $1.25 Million	-6,000 Reduced 10.91%	49,000 $9.25 Million
Q1 2021 May 17, 2021	SELL	$126.83 - $175.69 $6.34 Million - $8.78 Million	-50,000 Reduced 47.62%	55,000 $7.77 Million
Q2 2020 Aug 14, 2020	SELL	$104.21 - $156.44 $6.77 Million - $10.2 Million	-65,000 Reduced 38.24%	105,000 $15.6 Million
Q1 2020 May 15, 2020	SELL	$93.12 - $133.99 $5.12 Million - $7.37 Million	-55,000 Reduced 24.44%	170,000 $18.5 Million
Q4 2019 Feb 14, 2020	SELL	$74.51 - $124.23 $9.61 Million - $16 Million	-129,000 Reduced 36.44%	225,000 $25.9 Million
Q3 2019 Nov 14, 2019	BUY	$70.9 - $87.82 $992,600 - $1.23 Million	14,000 Added 4.12%	354,000 $28.5 Million
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $922,040 - $1.3 Million	14,000 Added 4.29%	340,000 $24.7 Million
Q4 2018 Feb 14, 2019	BUY	$62.67 - $88.33 $1.63 Million - $2.3 Million	26,000 Added 8.67%	326,000 $23.8 Million
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $9.71 Million - $11.9 Million	110,000 Added 57.89%	300,000 $29.5 Million
Q1 2018 May 15, 2018	SELL	$115.92 - $148.54 $1.16 Million - $1.49 Million	-10,000 Reduced 5.0%	190,000 $22.6 Million
Q4 2017 Feb 15, 2018	BUY	$114.49 - $139.98 $22.9 Million - $28 Million	200,000 New	200,000 $25.4 Million
Q4 2017 Feb 14, 2018	SELL	$114.49 - $139.98 $27.4 Million - $33.5 Million	-239,500 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$72.53 - $118.27 $2.21 Million - $3.61 Million	-30,500 Reduced 11.3%	239,500 $28.1 Million
Q4 2016 Dec 07, 2017	BUY	N/A	270,000	270,000 $10.1 Million

Others Institutions Holding ALNY

# of Institutions

643

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $28.9B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 683 Capital Management, LLC with notifications on news.

Account

683 Capital Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History